The Missing Link Between Your Child’s Gut and Their Brain

If you’ve been following this space for a while, you’ve read me talk about 2 things that might have seemed like separate stories.

One is the brain. The neurodevelopmental differences that show up in CHD kids: the cognitive patterns, the attention and processing challenges, the motor development that sometimes takes its own path. If you’ve read the CVC series (and especially the Neurodevelopmental Risk Map), you already know that these patterns begin before birth, shaped by altered blood flow, lower oxygen delivery to the fetal brain, surgical exposure, ICU time, and a cascade of factors that, for most of our kids, have already happened by the time we’re even asking the question.

The other is the gut. A couple of weeks ago I published a piece explaining that CHD children have measurably different gut microbiomes from their healthy peers; that the heart defect itself reshapes the bacterial ecosystem in the intestines through altered blood flow and oxygen levels; that surgery makes it worse; and that for Fontan patients, gut dysbiosis may be lifelong.

2 separate stories, 2 separate systems… except the research is increasingly showing they’re not separate at all. The gut and the brain have been talking to each other this whole time; and understanding that conversation might change how we think about both.

This isn’t a metaphor, mind you. There are specific, documented pathways through which gut bacteria communicate with the brain, and they start operating in early infancy (right when CHD kids are at their most vulnerable).

When gut bacteria break down the fiber we eat, they create these helpful molecules called short-chain fatty acids, or SCFAs (the Big 3 are butyrate, acetate and propionate). SCFAs do more than just keep our gut healthy; they travel through our blood to our brain and do several things that matter such as helping to reduce inflammation in the brain, supporting a molecule called BDNF (which is super important for neuron growth, connection and survival), and they help manage our stress response through the vagus nerve and the HPA axis.

In children with CHD, the gut isn’t as full of Bifidobacterium and other SCFA-producing bacteria as it should be, which means the communication between the gut and the rest of the body isn’t as strong as it should be. And since there aren’t as many messengers, the messages they send — like those that help reduce inflammation, protect the brain and manage stress — aren’t getting through as effectively.

The brain has its own protective barrier (the blood-brain barrier, or BBB) that controls what gets in from the bloodstream. What most people don’t realize is that gut bacteria actively help maintain this barrier. There was a research study not too long ago where mice were raised without any gut bacteria at all. Consequently, their BBB was leakier from before birth and stayed that way into adulthood; but when researchers introduced a healthy microbiome, the barrier tightened back up and key structural proteins (occludin, claudin-5) were restored!

Specific gut metabolites, including those SCFAs, help keep this barrier intact. In CHD children, where the gut barrier is already compromised and bacterial products are leaking into the bloodstream (a consequence of altered perfusion and surgical exposure we covered in the first gut article), the question becomes: is the brain’s border being affected too?

A study from 2024 in iScience (Yan et al.) revealed something really fascinating. Researchers discovered that in both rat pups with chronic low oxygen (aka hypoxia) and infants with cyanotic congenital heart disease (cCHD), low oxygen levels reduced certain gut bacteria, and that reduction resulted in an increase in cholic acid (a type of bile acid). In turn, this cholic acid activated immune cells in the brain, which caused changes in white matter — the same kind of white matter vulnerability that’s been documented in CHD newborns through MRI studies.

Here’s the part that matters in all this: when the researchers reloaded those depleted bacteria in the hypoxic rats, the white matter changes were rescued.

Now, context (because this is BTB and I’m not going to let a finding like that sit without it): this is animal model research confirmed in human tissue samples, not a clinical study following living CHD babies over time. While it doesn’t prove that giving a CHD infant probiotics will protect their white matter, it’s still the most specific mechanistic link found to date between gut dysbiosis and brain vulnerability in the context of chronic hypoxia; and that context is the daily reality for kids (like my own daughter) with cyanotic heart defects.

So, so far the pathways I’ve laid out tell us how the gut could be influencing the brain. But has anyone actually measured both gut composition and brain development in the same CHD children?

And the answer is … Yes. Barely.

A 2025 prospective study (Fundora et al., JPEN) followed 24 CHD infants and assessed both their gut microbiome and their Bayley Scales scores (standard clinical tool for measuring cognitive, language, and motor development).

(So I’m going to open a small parenthesis here, because words. I’ve been reading about prospective studies but couldn’t understand fully what it meant that one was prospective and another was… regular. So I looked it up and the difference between them is that prospective means the study is going to be studying its patients over time in the future, whereas a regular one (called retrospective) looks backwards in time using historical data or pre-existing medical records. That being said, let’s get back to our scheduled programming.)

The findings: Infants with lower gut microbial diversity scored lower on cognitive and language assessments. Less Bifidobacterium (the beneficial bacteria that should dominate the infant gut) correlated with worse cognitive and language scores. Higher levels of pro-inflammatory bacteria (Serratia, Acinetobacter, Proteus) correlated with lower motor scores.

In a related study (An et al. 2025), researchers looked at various biological factors and discovered that Escherichia, a type of bacterium known for its pro-inflammatory properties, was linked to the worst outcomes in neurodevelopment across several areas.

And here’s the pattern that I’ve kept seeing across all of these studies: the same bacterial fingerprint keeps showing up:

• Depleted Bifidobacterium.

• Overgrown Enterococcus and Enterobacteriaceae.

• Reduced SCFA production.

I started seeing that same pattern show up in not just the CHD gut research, but also in the depression and anxiety research literature, in neurodevelopmental studies, in intestinal barrier dysfunction, and in Fontan data (Yah… you should see (or not?) the stacks of papers I have spread around the house… my office, my living room rolling table, the couch. My rabbit-hole deep dives are lowkey legendary lol). So basically the same cast of characters keeps showing up in 5 different system malfunctions and the bacteria that are depleted in your child’s gut are the same ones researchers keep finding missing in study after study on brain development and mental health.

Fair Warning: this data is coming from small groups, so it’s not conclusive proof, and the researchers themselves say their results are just starting points for further investigation (“hypothesis-generating”). BUT… the biological reasons for this connection seem pretty solid, the direction is consistent, and the pattern is pretty hard to ignore.

If you’ve been following the neurodevelopmental story in CHD, like me you’ve spent a lot of time learning about factors you can’t change: the fetal hemodynamics, the surgery/-ies, the bypass time, CICU stay, oxygen levels… these things happened, and no amount of information after-the-fact gives you a do-over. Nor me.

But, from everything I’ve been digging through for weeks now, it seems to me that the gut is different, and that the microbiome is modifiable.

Not completely, not overnight, and not with a single supplement — but through real, evidence-supported strategies that are within a family’s reach. That makes the gut-brain connection not just another thing to know about, but potentially one of the few parts of this picture where we as parents — or CHDers — are not standing on the sidelines.

So what can families actually do with this? Welp, here’s where the CHD-specific evidence and the broader pediatric research meet.

From the CHD-specific literature:

• Maternal milk is still the best-supported way to go. The special sugars in human milk, called oligosaccharides, are what really help Bifidobacterium get settled in your baby’s gut. And Bifidobacterium is the kind of bacteria that’s linked to better brain development in studies. Giving babies with complex heart defects only human milk before surgery has been shown to lower the risk of necrotizing enterocolitis (NEC). But it’s not just about NEC; it’s about feeding the bacteria that makes the stuff that communicates with your baby’s brain.

• Enteral nutrition targets after surgery matter. Emerging evidence suggests that reaching feeding goals during the during the first few days after surgery can lead to better results without causing more problems in the gut, and earlier feeding means earlier gut recovery, which means getting SCFA production back to normal sooner.

• Antibiotic stewardship protects the bacteria you’re trying to support. From the studies I’ve dug into, it seems that researchers prefer to go with the narrowest spectrum and the shortest effective duration; otherwise, when you use a broad-spectrum antibiotic, it can mess with the balance of good bacteria in the baby’s gut, especially when they’re growing and developing.

From the broader pediatric evidence (for kids past the surgical window):

• Dietary fiber diversity feeds SCFA-producing bacteria. Think variety over volume: different fruits, vegetables, legumes, whole grains, nuts and seeds across the week. In other words: “plant points,” not perfection.

• Prebiotic-rich foods (bananas, onions, garlic, leeks, beans, lentils, whole grains) selectively nourish the beneficial bacteria. These are everyday foods, not supplements.

• Fermented foods (yogurt, kefir) where tolerated provide live microbes and are associated with favourable gut composition shifts.

• The mental health connection is worth knowing about, especially for parents of older children navigating mood, anxiety, or attention challenges. The same SCFA-producing bacteria depleted in CHD guts are the same ones consistently found to be reduced in depression and anxiety research in broader populations. The mechanisms are similar, too: neuro-inflammation, vagus nerve signalling, and HPA axis regulation. This doesn’t mean yogurt cures anxiety; it means supporting the gut ecosystem may be one thread in a larger tapestry of mental health support, and it’s a thread that costs nothing and carries no side effects.

On probiotic supplements specifically: Keep in mind that the effects can vary depending on the specific strain. Also, it’s important to think carefully about the safety of these supplements for post-op CHDers (just to let you know, though, that probiotic-related infections have been seen after cardiac surgery in children, but they’re not common). It’s best to chat with your child’s healthcare team about whether supplements are right for them rather than making a decision on your own.

Here’s something that could bother you, because it really bothers me (and I’m keeping a tight rein on my vocabulary choices here because I promised my sister).

The research community has established that gut dysbiosis exists in CHD children. Multiple studies have connected gut composition to neurodevelopmental markers. The mechanistic pathways linking gut to brain are documented and biologically plausible. And the number of CHD intervention trials that have measured neurodevelopmental or even mental health outcomes after a gut-targeted intervention is: zero.

Not one. Every single probiotic and synbiotic trial I could find in CHD has stopped at microbiome composition, barrier markers, or clinical outcomes like NEC and sepsis. I couldn’t find one that followed through to the brain.

You might reasonably ask, has it been tested in similar populations? Well… sort of. There’s a meta-analysis of 30 probiotic trials in preterm infants (Panchal et al. 2023) that found no neurodevelopmental benefit. Sounds pretty definitive, sure, until you look at the fine print: of those 30 trials, only 5 actually measured neurodevelopmental outcomes, and only 2 of the 7 studies reporting on brain-related outcomes had low risk of bias. And across the full set of trials, the probiotic formulations were a grab-bag of commercially available strains that were chosen simply because they were on hand, not because they matched the specific bacterial deficits documented in these infants. Doses ranged from 10 million to 50 billion CFU (Colony-Forming Unit). Durations varied. Timing varied. Nobody designed an intervention around the specific dysbiosis signature (Bifidobacterium deficiency, overgrown Enterococcus, reduced SCFA production) that the descriptive research keeps identifying.

Think of it this way: the antibiotic stewardship principle — narrowest spectrum, shortest effective duration — exists because a targeted approach works better than a broad one. Stands to reason that, considering everything that’s been learned about gut microbiomes through research and studies, that the same principle should apply to probiotics. But that hasn’t happened yet. What the preterm data tells the medical community looking into it isn’t “this doesn’t work.” It’s saying that blunt instruments, in a different population, measured the wrong outcomes. To me, that’s not discouraging; what I’m seeing is actually a clear set of instructions for what a proper study would actually need to look like.

Knowing this gap exists is in itself useful information! And frankly, it’s the kind of information that should make fellow CHD families productively frustrated. Here’s what I mean: a parent (you) who now understands that the research hasn’t asked the most important question, in the right population, with the right tools, is a parent (again, you) who can advocate for their child’s gut health as part of their neurodevelopmental care plan, not separate from it. Ask your child’s care team whether gut health is being considered alongside developmental follow-up. Ask why it isn’t, if it’s not! Bring this article if it helps start the conversation.

• I’m wondering if my child’s gut health is being included in their overall development plan.

• Also, are the antibiotics and acid suppressants my child is taking (if they’re taking them) still needed, and are they being used as effectively as possible?

• Could you tell me about the feeding plan and how it helps with gut recovery?

• Are there any microbiome-focused approaches being used at your centre for CHD patients?

• I’ve been learning about the gut-brain connection in CHD—does your team keep an eye on that?

Most of what shapes our children’s brain development is out of our hands. That is the hard truth this community — or any community, for that matter — lives with every day.

But the gut may be one piece of this picture where maybe we’re not limited to simply watching, and even though the science isn’t far enough along to make promises — still, it’s starting to point in a direction. And the strategies that support a healthy gut microbiome are low-risk, evidence-supported, and good for our kids regardless of what future research confirms.

To me, that’s not nothing.

More is coming in this series: the intervention gap, the deeper biology of what happens during and after surgery, some other stuff surely. But this is the focus piece I wanted you to have first, because it changes the framing of what we thought we knew all this time.

That the gut isn’t just about digestion. And that it might be part of how a child’s brain is being built, maintained, and supported, right now, every day, in ways that are still within reach.

Forewarned is forearmed.

Take heart,

— Marie-Jo 💕

1. The neurodevelopment connection: Fundora, M.P., et al. (2025). “Association between the gut microbiome and neurodevelopmental outcomes in infants with congenital heart disease: a prospective cohort study.” Journal of Parenteral and Enteral Nutrition (JPEN), 50, 236–246. — First study directly linking CHD gut microbiome composition to Bayley Scales outcomes. Lower diversity → lower cognitive and language scores; less Bifidobacterium → worse cognitive and language outcomes; pro-inflammatory bacteria → worse motor scores. Small (n=24) but prospective with validated instruments.

2. Multi-omics confirmation: An, Z., et al. (2025). “Serum metabolome and gut microbiome in CHD children with neurodevelopmental disorders.” Frontiers in Microbiology. — Escherichia most negatively associated with neurodevelopmental outcomes; linolenic acid most positively correlated across multiple domains.

3. The bile acid–brain mechanism: Yan, X., et al. (2024). “Gut microbiota-derived cholic acid mediates neonatal brain immaturity and white matter injury under chronic hypoxia.” iScience. — Most specific CHD-relevant gut-brain mechanism to date. Chronic hypoxia depletes gut bacteria → cholic acid accumulation → microglial activation → white matter changes. Bacterial replenishment rescued white matter changes in animal model.

4. Blood-brain barrier and microbiome: Braniste, V., et al. (2014). “The gut microbiota influences blood–brain barrier permeability in mice.” Science Translational Medicine, 6, 263ra158. — Landmark study: germ-free mice have leakier BBB from before birth; introducing a healthy microbiome restores barrier integrity and tight junction proteins (occludin, claudin-5).

5. The comprehensive CHD-gut review: Liu, Y., et al. (2023). “From heart to gut: Exploring the gut microbiome in congenital heart disease.” iMeta, 2, e144. — Most comprehensive review of the CHD-gut field; 173 references covering immunity, gut barrier, neurodevelopment, BBB integrity, and the perioperative period. Open access.

6. The staged CHD-gut framework: Luca, A.-C., et al. (2026). “The Gut Microbiome in Congenital Heart Disease: Dysbiosis, Intestinal Barrier Injury, and Translational Opportunities Across the Childhood — A Narrative Review.” Children, 13(5), 668. — Proposes a gut–heart–immune framework across neonatal, perioperative, and chronic stages. Includes an intervention taxonomy and safety discussion. Open access.

7. Preterm probiotic meta-analysis (neurodevelopment): Panchal, H., Athalye-Jape, G., Rao, S., & Patole, S. (2023). “Growth and neuro-developmental outcomes of probiotic supplemented preterm infants — a systematic review and meta-analysis.” European Journal of Clinical Nutrition, 77, 855–871. — 30 RCTs (n=4,817). Only 5 measured neurodevelopmental outcomes; only 2 of 7 studies reporting brain-related outcomes had low risk of bias. Generic probiotic formulations, not targeted to documented dysbiosis patterns. Important for understanding why existing data doesn’t answer the CHD-specific question.

8. Depression, anxiety and the gut microbiome: Gao, M., Wang, J., Liu, P., et al. (2023). “Gut microbiota composition in depressive disorder: a systematic review, meta-analysis, and meta-regression.” Translational Psychiatry, 13(1), 379. — 44 studies (2,091 patients, 2,792 controls). Consistent depletion of butyrate-producing genera (Coprococcus, Faecalibacterium) and enrichment of pro-inflammatory taxa (Enterococcus, Escherichia) in depressive disorder. Same bacterial signature as CHD dysbiosis.

9. Growth and microbiome: Fundora, M.P., et al. (2024). “Microbiome and Growth in Infants with Congenital Heart Disease.” Journal of Pediatrics, 274, 114169. — Companion to the neurodevelopment paper. Distinct gut patterns associated with lower weight and smaller head circumference in CHD infants.

The gateway article: Hérard, M.-J. (2026). “DECODED: Does Your Child’s Heart Defect Affect Their Gut?” Between the Beats. [link] — Part 1 of this series. Introduces CHD gut dysbiosis, the “second hit” of surgery, and practical strategies. Start here if you haven’t read it.

The content on Between the Beats is for informational and educational purposes only. While I’m involved in the CHD community, I’m not a medical professional. The insights, research translations, and personal experiences shared here aren’t a substitute for professional medical advice, diagnosis, or treatment.

Important Guidelines:

• Consult your team (cardiologist, surgeon, etc.) for any medical questions or treatment plans.

• Don’t disregard professional advice or delay care because of something you read here.

• Call your doctor or emergency services immediately if you think you have a medical emergency.

By using this site, you agree to these terms.